[Federal Register Volume 89, Number 78 (Monday, April 22, 2024)]
[Notices]
[Pages 29336-29337]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-08448]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Meeting of the Board of Scientific Counselors, Office of
Readiness and Response
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the
Centers for Disease Control and Prevention (CDC) announces the
[[Page 29337]]
following meeting for the Board of Scientific Counselors, Office of
Readiness and Response, (BSC, ORR). This virtual meeting is open to the
public. Time will be available for public comment.
DATES: The meeting will be held on May 23, 2024, from 10 a.m. to 4:30
p.m., EDT.
ADDRESSES: Zoom virtual meeting. If you wish to attend the meeting,
please register in advance by accessing the link at https://cdc.zoomgov.com/webinar/register/WN_kNZWpr8KRVGTGN0ERE_1Cg#/registration. Instructions to access the meeting will be provided
following registration.
FOR FURTHER INFORMATION CONTACT: Dometa Ouisley, Public Health Analyst,
Office of Science and Laboratory Readiness, Office of Readiness and
Response, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, Mailstop H21-6, Atlanta, Georgia 30329-4027. Telephone: (404) 639-
7450; Email: [email protected].
SUPPLEMENTARY INFORMATION:
Purpose: The Board of Scientific Counselors, Office of Readiness
and Response provides advice and guidance to the Secretary, Department
of Health and Human Services (HHS); the Assistant Secretary for Health,
HHS; the Director, Centers for Disease Control and Prevention (CDC);
and the Director, Office of Readiness and Response (ORR), CDC. The
Board recommends strategies and goals for readiness and response
activities pertaining to programs and research within the agency and
the ORR divisions and monitors the overall strategic direction and
focus of the ORR divisions and offices. The Board may also perform
second-level peer review of applications for grants-in-aid for research
and research training activities, cooperative agreements, and research
contract proposals relating to the broad areas within the center. For
additional information about the Board, please visit https://www.cdc.gov/orr/bsc/index.htm.
Matters to be Considered: Agenda topics for the meeting include:
(1) ORR Updates, (2) ORR Division Directors Follow-up Discussion, (3)
Polio Containment Working Group Updates, (4) Health Equity Working
Group Updates, and (5) ORR Science Agenda Presentation and Discussion.
Agenda items are subject to change as priorities dictate.
The Director, Office of Strategic Business Initiatives, Office of
the Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-08448 Filed 4-19-24; 8:45 am]
BILLING CODE 4163-18-P